Iron metabolism, free radicals, and oxidative injury (Q34322588)

1 August 2017

1 reference

title

Iron metabolism, free radicals, and oxidative injury (English)

1 reference

1 August 2017

1 reference

Emerit J

1

1 reference

PubMed ID

11478586

1 August 2017

Beaumont C

series ordinal

2

1 reference

PubMed ID

11478586

1 August 2017

Trivin F

series ordinal

3

1 reference

1 August 2017

1 July 2001

1 reference

Biomedicine and Pharmacotherapy

1 August 2017

1 reference

1 August 2017

55

1 reference

1 August 2017

333-339

1 reference

1 August 2017

6

1 reference

Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Fluorescence analysis of the labile iron pool of mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

On the limited ability of superoxide to release iron from ferritin

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

The ferritins: molecular properties, iron storage function and cellular regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Disorders of iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Linkage of cell-mediated immunity to iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

1 reference

7 January 2021

Structure and dynamics of the iron responsive element RNA: implications for binding of the RNA by iron regulatory binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Ferritin levels in pediatric HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Biological and clinical significance of haptoglobin polymorphism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Serum Ferritin, Desferrioxamine, and Evolution of HIV-1 Infection in Thalassemic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Bark, weeds, and iron chelators--drugs for malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Response to interferon alpha therapy is influenced by the iron content of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Iron-induced carcinogenesis: the role of redox regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Free radicals and the etiology of colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Iron and the sex difference in heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Iron metabolism in the erythrophagocytosing Kupffer cell

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Paraquat toxicity is enhanced by iron and reduced by desferrioxamine in laboratory mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Failure of desferrioxamine to modify the toxicity of paraquat in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900068-3

7 January 2021

10.1016/S0753-3322(01)00068-3

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11478586